comparemela.com

Latest Breaking News On - Katharina nothelfer - Page 1 : comparemela.com

AiCuris Anti-infective Cures AG: AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients

AiCuris Anti-infective Cures AG: AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS(R) for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients

AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS(R) for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approva

PREVYMIS® now approved in the U.S. and Europe for prophylaxis of Cytomegalovirus (CMV) disease in adult kidney transplant recipients at high risk (Donor CMV seropositive/Recipient CMV seronegative [D+/R‑])EMA approval triggers a €15 Million Milestone payment to AiCuris and AiCuris is eligible for further milestone p.

AiCuris Anti-infective Cures AG: AiCuris AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients

AiCuris Anti-infective Cures AG: AiCuris AiCubator Program Opens New Application Round for Innovative Projects with Focus on Treatment Options for Viral Infections in Immunocompromised Patients
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

AiCuris Anti-infective Cures AG: AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U S FDA Approval of PREVYMIS in Second Indication

AiCuris Anti-infective Cures AG: AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U S FDA Approval of PREVYMIS in Second Indication
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.